Clin2
NCT07884110Worth exploringRecruiting

Liver transplant for colorectal cancer

Colorectal CancerLiver Metastasis

Part of Cancer, Digestive system clinical trials.

This trial studies whether a liver transplant can be a safe and effective treatment for people with colorectal cancer that has spread only to the liver and cannot be removed with surgery. It aims to remove the liver tumors and replace the liver with a healthy one, potentially offering a chance for a longer, cancer-free life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have colorectal cancer that has spread only to the liver, and the liver tumors cannot be surgically removed.
  • You had surgery to remove the original colorectal tumor at least 6 months ago, with clear margins and no signs of the cancer coming back in the colon or rectum.
  • Your cancer has responded to at least 6 months of systemic therapy (like chemotherapy), shown by imaging and a blood test for CEA.
  • You have no cancer spread outside the liver, are generally in good health (able to do daily activities), and have a CEA level below 80.
  • Your tumor type is specific: it is not BRAF-mutated and is microsatellite stable, and you have a potential living liver donor who meets medical and legal criteria.
  • An official transplant committee has approved you as a good candidate for a liver transplant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05398380Recruiting
Liver transplant for colorectal liver cancer that can’t be removed

This trial studies liver transplantation for certain people with colorectal cancer that has spread only to the liver and cannot be removed with surgery. It aims to improve outcomes for carefully selected patients whose cancer is controlled on chemotherapy and who meet specific safety and scan requirements.

Barcelona, Barcelona
NCT04616495Recruiting
Liver transplant for colorectal cancer that can’t be removed

This trial studies liver transplantation for people with colorectal cancer that has spread to the liver but cannot be surgically removed. It aims to see if transplant can improve outcomes when the cancer is limited to the liver.

Valencia
NCT05185245Recruiting
Liver transplant for colorectal cancer spread to the liver

This study looks at whether a liver transplant can help people whose colorectal cancer has spread to the liver but cannot be removed by surgery. It also checks whether certain cancer features, treatment history, and blood/health status make transplant safer or more effective.

Bologna
NCT01479608Recruiting
Liver transplant for colon or rectal cancer liver spread

This trial studies whether a liver transplant can help people with colon or rectal cancer that has spread to the liver (but not elsewhere). It aims to improve outcomes by removing the diseased liver when the cancer has responded to chemotherapy and can still be controlled.

Oslo
NCT02215889Recruiting· Phase 1/Phase 2
Partial liver transplant for colon or rectal cancer spread to liver

This trial tests whether transplanting part of the liver can help people with colon or rectal cancer that has spread to the liver but cannot be removed with surgery. It also aims to make sure the cancer is limited mainly to the liver and that you are healthy enough for major treatment.

Oslo
NCT03494946Recruiting
Liver transplant vs chemotherapy for colon cancer liver spread

This trial compares liver transplantation to standard chemotherapy for people with colon or rectal cancer that has spread to the liver but cannot be removed surgically. It looks at whether transplant can help patients live longer or better than chemotherapy in the right patients.

Oslo

Hear when a new Colorectal cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.